questions & answers


The doctor probably told your loved one there are no treatment options left for him. In general treatment protocols can vary: not only from one country to another, but also from one hospital to another. This may affect your loved one’s opportunity to have access to the latest insights and therapies. On top of that, the doctor’s experience with the disease is probably one of the most important factors in receiving the best suitable treatment for your loved one’s specific situation.

For example, when using exactly the same protocol, a doctor who treats more than 20 patients on a yearly basis will probably have better results than a doctor who only treats five patients a year.

So if your time and energy allow it, it could be worthwhile to find out which doctor in your country or abroad has solid experience in treating your loved one’s disease and uses the latest techniques and treatment protocols. Your loved one’s doctor should be able to help you with this process. Experiences of fellow patients might provide valuable insights as well. You might find these patients at our Fighters Forum. Your loved one could get a second opinion from such an experienced doctor to make sure he receives the best possible treatment currently available.

We’re continuously expanding the number of Fast Track Treatments we can offer to patients in need. It might be that we can’t offer a FTT for a patient in need right now, but will be able to offer a treatment possibility in the near future. To make sure you receive such news as quickly as possible, you can sign up for the myTomorrows Alert. You can simply select the disease(s) of interest and register your email address and phone number. You’ll receive an email from myTomorrows and by clicking on the confirmation link, you confirm your registration. This means you’ll be included in our mailing list and you’ll receive a notification as soon as we can offer a Fast Track Treatment for the disease area(s) selected by you.

If you don’t want to receive the myTomorrows Alert anymore, you can simply fill in your email address again without selecting any diseases of interest. You won’t receive any notifications anymore.

That’s totally up to your loved one. Only he can determine if he wants to grab such an extra treatment option. We did an international survey amongst patients without treatment options left and the results show that a substantial part of these patients seriously doubts if they would want such a treatment. Of course that’s fine. We strongly support that anyone can decide about his or her own life, so we fully respect that choice. However, the results of the survey also showed that the majority of the patients without treatment options left want to grab extra opportunities. And for those people we try our best to create opportunities. Of course we respect every patient that decides otherwise.

Yes. Your loved one cannot start a Fast Track Treatment without the involvement of a registered doctor. We at myTomorrows think it’s up to your loved one to decide about his own life, so also about his treatment. However, your loved one can and should share that responsibility with a professional doctor. Your loved one’s doctor knows him and the progression of the disease, the physical condition and the treatment so far. So the doctor is a valuable partner in deciding what is best for your loved one. Together they determine if there are still treatment options available to your loved one.

The doctor submits a Fast Track Treatment request with myTomorrows if he or she wants to prescribe the medicine to your loved one. From that moment onwards we can take care of things. We check if the doctor is registered and we take care of the request for approval that will be sent to the regulatory authorities. As soon as the regulatory authorities have reviewed and approved the doctor’s treatment request and your loved one paid for the medicine, it will be delivered to your loved one’s pharmacy or the hospital pharmacy. Your doctor remains responsible for your loved one’s treatment while using this medicine.

In our view the doctor is an important advisor, but ultimately it’s your loved one’s life we’re talking about. If your loved one has good reasons to disagree with the doctor, he should think carefully before changing to another doctor. The doctor can probably perfectly explain his or her point of view.

If such an explanation doesn’t satisfy, a second opinion from another doctor might help. Sometimes it’s possible to request a second opinion via your loved one’s own doctor. Sometimes patient recommendations can help you to find another doctor. This research probably takes time and energy, but if you want to fight it’s worthwhile.

Yes, but anonymized and complying with privacy legislation. We make the uncensored anonymized treatment data available to doctors who consider starting a Fast Track Treatment for their patients. These doctors can share the data with their patients.

Next to that we share these data with the drug developer of the medicine, so the company receives valuable real life data that clinical trials alone cannot. These data can help the drug developer to better manage the development of the medicine.

myTomorrows can help seriously ill patients that don’t have any treatment options left or suffer from a severe (chronic) disease that step-by-step reduces their quality of life. We at myTomorrows can offer earlier access to promising medicines that are not yet authorized. We call this a Fast Track Treatment. As a patient you will need the support of your doctor and your request for such a Fast Track Treatment needs to be approved by the regulatory authorities. We offer up-to-date information about potential Fast Track Treatment opportunities for you and a community where you can get in touch with fellow patients, loved ones of fellow patients and doctors.

We do our utmost to make sure that a patient who is willing and able to continue to fight, can benefit from the latest innovations. However, we have to be realistic: these treatment options won’t be effective for everyone. Please be aware of this as well.

You as well as your doctor can initiate the request for a Fast Track Treatment: earlier access to a promising medicine that isn’t registered yet.

You, your loved one and your doctor can register on our platform to access general information about a Fast Track Treatment via myTomorrows. Your doctor can request more detailed information, such as anonymized real life treatment data from other patients who started a Fast Track Treatment. Your doctor can share this information with you and together you can make an informed decision about the Fast Track Treatment.

If you and your doctor decide to start a Fast Track Treatment, your doctor submits the request to myTomorrows. We coordinate the necessary request with the regulatory authorities. As soon as this request is approved and you paid for the medicine, we make sure your pharmacy or the hospital pharmacy receives the medicine as soon as possible.

During the treatment you and your doctor can fill in your treatment results. These data will be anonymized. Other patients like you and their doctors can benefit from these data. It can help them to make an informed decision as well. If regulatory authorities request reporting, we will take care of that as much as possible for your doctor.

myTomorrows can help seriously ill patients that don’t have any treatment options left or suffer from a severe (chronic) disease that step-by-step reduces their quality of life.

We focus primarily on neurological diseases, cancer and rare diseases. For those diseases we currently offer some Fast Track Treatments. You can find those on our website. In order to help as many patients as possible that want to and are able to fight their illness, we rapidly increase the number of Fast Track Treatments for these diseases.

In our view your doctor is an important advisor, but ultimately it’s your life we’re talking about. If you have good reasons to disagree with your doctor, think carefully before changing to another doctor. Your doctor can probably perfectly explain his or her point of view.

If such an explanation doesn’t satisfy you, a second opinion from another doctor might help you and your doctor to define the next step together. Sometimes it’s possible to request a second opinion via your own doctor. Sometimes patient recommendations can help you to find another doctor. This research probably takes time and energy, but if you want to continue your fight it’s worthwhile.

Your doctor probably told you there are no treatment options left for you. In general treatment protocols can vary: not only from one country to another, but also from one hospital to another. This may affect your opportunity to have access to the latest insights and therapies. On top of that, your doctor’s experience with your disease is probably one of the most important factors in receiving the best suitable treatment for your specific situation.

For example, when using exactly the same protocol, a doctor who treats more than 20 patients on a yearly basis will probably have better results than a doctor who only treats five patients a year.

So if your time and energy allow it, it could be worthwhile to find out which doctor in your country or abroad has solid experience in treating your disease and uses the latest techniques and treatment protocols. Your own doctor should be able to help you with this process. Experiences of fellow patients might provide valuable insights as well. You might find these patients at our Fighters Forum. Get a second opinion from such an experienced doctor to make sure you receive the best possible treatment currently available.

That’s totally up to you. Only you can decide if you want an extra treatment opportunity. We did an international survey amongst patients without treatment options left and the results show that a substantial part of these patients seriously doubts if they would want such a treatment. Of course that’s fine. We strongly support that anyone can decide about his or her own life, so we fully respect that choice. However, the results of the survey also showed that the majority of the patients without treatment options left want to grab extra opportunities. And for those people we try our best to create opportunities. Of course we respect every patient that decides otherwise. If you don’t want an extra treatment opportunity or if it’s your doctor’s professional opinion that you can’t benefit from such a treatment anymore, end-of-life care can support you and your loved ones. You can spend the time you have left together and focus on saying farewell to your loved ones

Your company develops a medicine for a neurological disorder, cancer or a rare disease. This medicine shows promising results during clinical trials, but it doesn’t have marketing authorization yet.

You are driven by the unmet medical need and the solution that your company is working on. You sympathize with patients who don’t have treatment options left while your company develops a potentially life-improving medicine.

Working with myTomorrows enables you to make sure patients in need can benefit from your medicine as soon as possible. We create earlier access and call this Fast Track Treatments.

Doctors can request your medicine on behalf of their patients via the myTomorrows platform. As soon as they start using your medicine, your company receives anonymized ‘real-life’ treatment data from these patients and their doctors. Your company can use these data to further tune the development of the medicine and to better define the patient population in which the medicine has the most beneficial efficacy/safety balance. This supports next phase trial design and, ultimately, a more efficient and faster development process.

Your company will also generate revenues in the process. The revenue reflects a healthy balance between your company’s interests and our aim to make Fast Track Treatments affordable to as many patients as possible.

Data. Positive treatment data are essential to commit investors, patients and their doctors. Convincing investors to finance the development of promising medicines proves to be difficult nowadays. The lengthy authorization processes of medicines make this even more challenging. But positive treatment data are essential to win over potential investors. Positive treatment data also mean your medicine improved the lives of patients in need, hence doctors and their patients will be committed to your company, now as well as after registration of your medicine.

Yes. You can’t start a Fast Track Treatment without the involvement of a registered doctor. We at myTomorrows think it’s up to you to decide about your own life, so also about your treatment. However, you can and should share that responsibility with a professional doctor. Your doctor knows you and the progression of your disease, your physical condition and your treatment so far. So your doctor is your best partner in deciding what is best for you. Together you determine if there are still treatment options available to you.

Your doctor submits a Fast Track Treatment request to myTomorrows if he or she wants to prescribe the medicine to you. From that moment onwards we can take care of things. We check if your doctor is registered and we take care of the request for approval that will be sent to the regulatory authorities. As soon as the regulatory authorities have reviewed and approved your doctor’s treatment request with this medicine and you’ve paid for the medicine, your pharmacy or the hospital pharmacy will receive the medicine via us. Your doctor remains responsible for your treatment while you use this medicine.

myTomorrows helps seriously ill patients who don’t have treatment options left or people who suffer from a severe (chronic) disease that reduces their quality of life over time.

In order to help as many patients in need as possible, we are rapidly increasing the number of Fast Track Treatments. Therefor we are cooperating with many innovative drug developers around the globe.

No. We create freedom of choice. With the support of your doctor and after approval by the regulatory authorities, you can choose earlier access to a promising medicine that is being developed and probably won’t be authorized in time for you. Via your doctor we provide you with the necessary information about the medicine. This will help you and your doctor to make an informed decision together about starting a Fast Track Treatment or not. A Fast Track Treatment is always a medicine that isn’t authorized yet. It could potentially relief your suffering, extend your life or even save you. At the same time it has the risk of no efficacy and of unknown side effects. You should be aware of that.

myTomorrows can offer you as a doctor extra treatment possibilities with promising medicines that show positive results during clinical trials, but aren’t authorized yet. Such a treatment possibility, a Fast Track Treatment, could be an alternative for patients that don’t have any treatment options left.

Next to that we can give you clear and up-to-date information about medical research within the different diseases we focus on. We also provide 24/7 ‘real life’ treatment data of Fast Track Treatments via myTomorrows. Patients and their doctors share these data, of course anonymized. The collection of these data starts as soon as the first patient is being treated with a specific medicine via a Fast Track Treatment. As the number of patients increases, the available data grow as well. This can help to make an informed decision together with your patient about such an extra treatment possibility.

We do our utmost to make sure that a patient who is willing and able to continue to fight, can benefit from the latest innovations. However, we have to be realistic: these treatment options won’t be effective for everyone. Patients should be aware of this as well.

For each disease you can find information about Fast Track Treatments here. We aim to offer multiple Fast Track Treatments for each disease. We are not yet able to offer Fast Track Treatments for every disease. If a disease isn’t mentioned on our website, this means we haven’t found a promising medicine that we were able to discuss with the developer yet. It’s still worthwhile to register at myTomorrows, even if there aren’t Fast Track Treatments available for you yet. Questions from patients in need and their doctors guide us. If multiple patients and their doctors need a treatment for the same disease, we have an extra incentive to research opportunities. And of course we immediately inform you as soon as relevant Fast Track Treatments become available via myTomorrows.

myTomorrows wants to be completely transparent and uncensored towards you and your doctor about the newest medicines and treatment results. However, that isn’t allowed under current legislation. Communication with patients and doctors about medicines is strictly regulated. Regulators quickly consider information about a medicine to be surreptitious advertising. And advertising a medicine isn’t at all what myTomorrows aims to do. myTomorrows wants to offer you the latest options now that you don’t have any time to lose. That’s why we are in close contact with regulators to ensure that we can inform you as much as possible about the medicine without namedropping.

myTomorrows can help seriously ill patients that don’t have any treatment options left or suffer from a severe (chronic) disease that step by step reduces their quality of life.

We focus primarily on neurological diseases, cancer and rare diseases. For those diseases we currently offer some Fast Track Treatments. You can find those on our website. In order to help as many patients as possible that want to and are able to fight their illness, we rapidly want to increase the number of Fast Track Treatments for these diseases.

After registration, you and your loved one can access general information about the Fast Track Treatment via myTomorrows. Your doctor can access additional information such as the anonymized real life treatment data from other patients who started this Fast Track Treatment and your doctor can share this information with you. Next to that our doctors are more than happy to assist, so you and your doctor can make an informed decision based on the latest scientific developments.

myTomorrows constantly explores the world in search of promising medicines. We approach companies that have shown promising results with medicines. We judge the medicine, but we also consider whether the company would be a reliable partner for you, your doctor and for myTomorrows. We focus on medicines that at least successfully finished phase I of a clinical trial. At that stage its safety has been tested and there are promising efficacy indications. However, there isn’t hard evidence for its efficacy yet. We could also offer a medicine at a later stage of the medicine development, for example during phase 2B of a clinical trial. At that stage there’s more evidence that suggests the medicine’s efficacy. At what moment we offer a medicine via a Fast Track Treatment always depends on the severity of the disease, the rareness of it and the availability of other treatment options for patients in need.

You, as well as your patient, can initiate the request for such a Fast Track Treatment: earlier access to a promising medicine that isn’t registered (yet).

You as a doctor and your patient can register on our platform to access general information about a Fast Track Treatment via myTomorrows. Only you as a doctor can request more detailed information, such as anonymized real life treatment data from other patients who started a Fast Track Treatment. You can share this information with your patient and together you can make an informed decision about the Fast Track Treatment.

If you and your patient decide to start a Fast Track Treatment, you as a doctor can submit the request to myTomorrows. We coordinate the necessary request with the regulatory authorities. As soon as this request is approved and your patient has paid for the medicine, we make sure your patient’s pharmacy or the hospital pharmacy receives the medicine as soon as possible.

During the treatment you and your patient can fill in treatment results. These data will be anonymized. Other patients and their doctors can benefit from these data. It can help them to make an informed decision as well. If regulatory authorities request reporting, we will take care of that as much as possible for you.

Yes, but anonymized and complying with privacy legislation. We make the uncensored anonymized treatment data available to doctors who consider starting a Fast Track Treatment for their patients. These doctors can share the data with their patients.

Next to that we share the anonymized treatment data with the drug developer of the medicine, so the company receives valuable real-life data that clinical trials alone cannot. These data can help the drug developer to better manage the development of the medicine.

No. We create freedom of choice. With your support and after approval by the regulatory authorities, your patient can choose earlier access to a promising medicine that is being developed and probably won’t be authorized in time for him. We provide you as a doctor with the necessary information about the medicine and you can share this with your patient. This will help you and your patient make an informed decision together about starting a Fast Track Treatment or not. A Fast Track Treatment is always a medicine that isn’t authorized yet. It could potentially relief your patient’s suffering, extend his life or even save him. At the same time it has the risk of no efficacy and of unknown side effects. Your patient should be aware of that.

Yes, but anonymized and complying with privacy legislation. We make the uncensored anonymized treatment data available to doctors who consider starting a Fast Track Treatment for their patients. These doctors can share the data with their patients.

Next to that we share the anonymized treatment data with the drug developer of the medicine, so the company receives valuable real-life data that clinical trials alone cannot. These data can help the drug developer to better manage the development of the medicine.

If you register on our Fighters Community your profile name is public and visible for every visitor. You can choose your profile name when your register. You can also add a photo, indicate that you’re a family/friend of a patient, add the disease and add additional information if you wish to. This information is also public and visible for every visitor.

 

If your loved one registers as a patient for a Fast Track Treatment on the platform, a secured medical file will be created for him. This electronic medical file is, for security reasons, entirely separated from the profile on the Fighters Community. Your loved one decides who is allowed to access this medical file.

You can rest assured that your loved one’s medical details are properly secured. The patient details in our database are encrypted according to established methods that are also being used for international payment transactions between banks. The encryption ensures your loved one’s details are useless in the unlikely event that other people gain illegal access to the database.

Next to that your loved one can delete the electronic medical file whenever he wants. myTomorrows can’t influence this. myTomorrows can only access the anonymized treatment data that don’t include your personal details.

The treatment results you and your doctor add to your electronic medical file are, together with the treatment data from other patients with the same Fast Track Treatment, completely anonymized and uncensored available. We use these data to inform other patients and doctors as much as possible, so they can make an informed decision about whether to start the Fast Track Treatment.

Your company develops a medicine that could improve or even save the lives of patients in need. Testing up until now has proven its safety and has shown promising efficacy results, but the authorization process isn’t finalized. Patients without treatment options left could seriously benefit from your medicine even though it isn’t registered yet. That’s where myTomorrows comes in.

Together we draft a Fast Track Treatment rollout plan, consisting of the geographical regions, a first estimate of patient numbers, logistics and pharmacovigilance set-up. Your company shares the necessary information about the medicine with us, including the GMP certificate and information brochure. If patients and their doctors request information about the medicine, we can inform them accordingly. Finally, we determine together what anonymized real-life treatment data from patients are valuable for your company.

If a patient and his or her doctor decide to request a Fast Track Treatment, myTomorrows prepares the request for the regulatory authorities on behalf of the doctor. As soon as the regulatory authorities approve the request, the Fast Track Treatment can start. myTomorrows manages the logistics of dispatching the medicine to the pharmacist and takes care of pharmacovigilance. Your company gets access to real-life anonymized safety and treatment data of patients who use your medicine.

By combining our efforts like this, we create an alternative for patients in need who have no time to await market approval.

We only select medicines that have proven to be safe during clinical trials. And we provide the necessary information about a Fast Track Treatment that will help your loved one and the doctor to make an informed decision.

Meanwhile your loved one probably knows a lot about his disease, but of course his doctor is the expert. The doctor knows your loved one and your loved one’s medical history very well. That’s why the doctor is responsible for the advice given to your loved one. The doctor is also responsible for the treatment with this medicine.

The real-life treatment data offer crucial information your company can benefit from in various ways: it can help to better manage your product development, while positive treatment data are essential to commit investors, doctors and patients to your company.

The compensation your company receives from each patient who uses your medicine – an additional source of income – adds to your company’s financial health.

Absolutely not, it’s exactly the other way around. Your loved one’s needs come first. We often search for promising medicines on behalf of or even with patients that are fighting their illness.

We work within the existing international legislation for early access/compassionate use. Regulatory authorities and professional doctors judge if the medicine prescribed by your loved one’s doctor – and via myTomorrows earlier accessible – is indeed suitable for your loved one. Only after the regulatory authorities approve the request for treatment with this medicine, myTomorrows can deliver the medicine.

Although most drug developers are enthusiastic about working with myTomorrows, some are reluctant. These drug developers fear they will lose control. The uncensored treatment data of patients who use your company’s medicine will be made available to doctors and their patients. We will be transparent.

Next to that, the real-life patients will be much more diverse than the group of patients included in a clinical trial. It is always the doctor who will decide if the patient can benefit from your company’s medicine.

For each disease you can find information about Fast Track Treatments here. We aim to offer multiple Fast Track Treatments for each disease. We are not yet able to offer Fast Track Treatments for every disease. If a disease isn’t mentioned on our website, this means we haven’t found a promising medicine that we were able to discuss with the developer yet. It’s still worthwhile to register at myTomorrows, even if there aren’t Fast Track Treatments available for your loved one yet. Questions from patients in need, their loved ones and their doctors guide us. If multiple people need a treatment for the same disease, we have an extra incentive to research opportunities. And off course we immediately inform you as soon as relevant Fast Track Treatments become available via myTomorrows.

Yes. A patient can’t initiate a Fast Track Treatment without the involvement of a registered doctor. We at myTomorrows believe it’s up to the patient to decide about his or her own life, thus also about the treatment. However, in the end it’s always the doctor who has to prescribe the medicine to the patient.

Your company is responsible for the quality of the product, but the doctor remains responsible for the patient’s treatment with this medicine.

myTomorrows wants to be completely transparent and uncensored towards you, your loved one and the doctor about the newest medicines and treatment results. However, that isn’t allowed under current legislation. Communication with patients and doctors about medicines is strictly regulated. Regulators quickly consider information about a medicine to be surreptitious advertising. And advertising a medicine isn’t at all what myTomorrows aims to do. myTomorrows wants to offer the latest options now that your loved one doesn’t have any time to lose. That’s why we are in close contact with regulators to ensure that we can inform you as much as possible about the medicine without namedropping.

myTomorrows constantly explores the world in search of promising medicines. We approach companies that have shown promising results with medicines for life threatening diseases. We focus on medicines that have proven to be safe and show promising indications of efficacy in clinical trials.

So we look at the medicine, but we also consider whether your company will be a reliable partner for patients, doctors and myTomorrows. An obvious example is supply: every patient who starts a Fast Track Treatment should be able to finish it.

After registration, you and your loved one can access general information about the Fast Track Treatment via myTomorrows. Your loved one’s doctor can access additional information such as anonymized real life treatment data from other patients who started this Fast Track Treatment and the doctor can share this information with your loved one. Next to that our doctors are more than happy to assist, so your loved one and the doctor can make an informed decision based on the latest scientific developments.

Yes. The anonymized real-life treatment data that patients and their doctors share with us are available to your company. Your company can use these data to better manage the development of the medicine and to better define the patient population in which the medicine has the most beneficial efficacy/safety balance. This enables better-designed trials and ultimately a more efficient drug development process.

myTomorrows constantly explores the world in search of promising medicines. We approach companies that have shown promising results with medicines. We judge the medicine, but we also consider whether the company would be a reliable partner for your loved one, the doctor and for myTomorrows. We focus on medicines that at least successfully finished phase I of a clinical trial. At that stage its safety has been tested and there are promising efficacy indications. However, there isn’t hard evidence for its efficacy yet. We could also offer a medicine at a later stage of the medicine development, for example during phase 2B of a clinical trial. At that stage there’s more evidence that suggests the medicine’s efficacy. At what moment we offer a medicine via a Fast Track Treatment always depends on the severity of the disease, the rareness of it and the availability of other treatment options for patients in need.

We at myTomorrows are social entrepreneurs. Social enterprises focus on solving unmet needs within society. Some social entrepreneurs choose for a charity model, others for a commercial approach. myTomorrows believes innovation and entrepreneurship can change the world. It goes without saying that myTomorrows has chosen the commercial approach of social entrepreneurship in order to create impactful sustainable change. We believe in free entrepreneurship and in organizations that are able to finance themselves. A healthy for profit attitude creates innovation. Well-meant initiatives like nonprofit organizations risk bureaucracy and inefficiency. That’s why myTomorrows has profit targets, but with a healthy balance between creating meaning and earning money.

 

myTomorrows can help seriously ill patients that don’t have any treatment options left or suffer from a severe (chronic) disease that step-by-step reduces their quality of life. We at myTomorrows can offer earlier access to promising medicines that are not yet authorized. We call this a Fast Track Treatment. Your loved one will need the support of his doctor and the request for such a Fast Track Treatment needs to be approved by the regulatory authorities. We offer up-to-date information about potential Fast Track Treatment opportunities for you and your loved one and a community where you can get in touch with other patients, loved ones of other patients and doctors.

We do our utmost to make sure that a patient who is willing and able to continue to fight, can benefit from the latest innovations. However, we have to be realistic: these treatment options won’t be effective for everyone. Please be aware of this as well.

We want to help as many patients as possible and we don’t make money at your costs. As long as a medicine that we offer via a Fast Track Treatment isn’t registered yet, myTomorrows doesn’t profit from it. You as a patient pay myTomorrows charges that cover the costs to organize a Fast Track Treatment for you.

As soon as the medicine is approved and commercially available in a certain region, myTomorrows will start to profit as well. After market approval of the medicine myTomorrows receives a small royalty from the developer. From that moment onwards we don’t offer the medicine via a Fast Track Treatment anymore in that region, because it’s a registered medicine that is publicly available for all patients.

No. We collaborate with any registered and certified doctor and with any hospital that is willing to realize a Fast Track Treatment for you. Having said that, we strongly believe in specialized centers, so we value collaboration with such centers. Whoever we collaborate with, your best interest always comes first.

myTomorrows can help seriously ill patients that don’t have any treatment options left or suffer from a severe (chronic) disease that step-by-step reduces their quality of life.

We focus primarily on neurological diseases, cancer and rare diseases. For those diseases we currently offer some Fast Track Treatments. You can find those on our website. In order to help as many patients as possible that want to and are able to fight their illness, we rapidly increase the number of Fast Track Treatments for these diseases.

In order to offer options to patients in need, myTomorrows works with drug developers. Those are mostly small, innovative biotech- and pharma companies. However, if a bigger company wants to create earlier access to one of their promising medicines, we would seize that opportunity with both hands as well.

We never get money from them or from other companies while the medicine is not yet officially approved. After official approval and market access, we will receive a small royalty from the developer. A few of our team members have worked at pharmaceutical companies in the past. That’s why we know the strengths and the weaknesses of that sector. We use that knowledge to improve drug development.

Definitely. As a patient you always come first. And in many ways patient organizations in a lot of countries have your best interest at hart. That’s why we feel connected to patient organizations and why we’re more than happy to work with them.

However, not every patient organization has embraced the Fast Track Treatment possibilities that were created by the legislator for patients like you. Some patient organizations have a more traditional approach and emphasize the importance of saying farewell to loved ones at this stage of your life. Although we also feel that is important, we focus on the people that want to and are able to continue their fight. Other patient organizations keep the interests of their sponsors in mind. We understand that, but we feel that’s not always in your best interest. And that’s why we choose differently. Politics as well as lobbyists can also greatly influence the policy of a patient organization in some countries. As long as you and fellow patients better from it, that’s fine. Unfortunately that’s not always the case. At that point we also distance ourselves from such a patient organization. We believe that innovative advancements should be made available as soon as possible. And not just to the happy few, but to as many patients possible that don’t have any time to lose.

 

Because we focus on innovation and advancement, we particularly experience a natural click with patients that took command and founded a new type of patient organization where using the wisdom of the crowd is essential. Great examples are patientslikeme.com and patientsknowbest.org.

Your loved one as well as his doctor can initiate the request for such a Fast Track Treatment: earlier access to a promising medicine that isn’t registered yet.

You, your loved one and your doctor can register on our platform to access general information about a Fast Track Treatment via myTomorrows. The doctor can request more detailed information, such as anonymized real life treatment data from other patients that started a Fast Track Treatment. The doctor can share this information with your loved one and together they can make an informed decision about a Fast Track Treatment.

If your loved one and his doctor decide to start a Fast Track Treatment, the doctor submits the request to myTomorrows. We coordinate the necessary request with the regulatory authorities. As soon as this request is approved and your loved one has paid for the medicine, we make sure your loved one’s pharmacy or the hospital pharmacy receives the medicine as soon as possible.

During the treatment your loved one and his doctor can fill in the treatment results. These data will be anonymized. Other patients like your loved one and their doctors can benefit from these data. It can help them to make an informed decision as well. If regulatory authorities request reporting, we will take care of that as much as possible for the doctor.

We at myTomorrows are social entrepreneurs. Social enterprises focus on solving unmet needs within society. Some social entrepreneurs choose for a charity model, others for a commercial approach. myTomorrows believes innovation and entrepreneurship can change the world. It goes without saying that myTomorrows has chosen the commercial approach of social entrepreneurship in order to create impactful sustainable change. We believe in free entrepreneurship and in organizations that are able to finance themselves. A healthy for profit attitude creates innovation. Well-meant initiatives like nonprofit organizations risk bureaucracy and inefficiency. That’s why myTomorrows has profit targets, but with a healthy balance between creating meaning and earning money.

We want to help as many patients in need as possible and we don’t make money at your loved one’s costs. As long as a medicine that we offer via a Fast Track Treatment isn’t registered yet, myTomorrows doesn’t profit from it. Your loved one pays myTomorrows charges that cover the costs to organize a Fast Track Treatment for him.

As soon as the medicine is approved and commercially available in a certain region, myTomorrows will start to profit as well. After market approval of the medicine myTomorrows receives a small royalty from the developer. From that moment onwards we don’t offer the medicine via a Fast Track Treatment anymore in that region, because it’s a registered medicine that is publicly available for patients.

In order to offer options to patients in need, myTomorrows works with drug developers. Those are mostly small, innovative biotech- and pharma companies. However, if a bigger company wants to create earlier access to one of their promising medicines, we would seize that opportunity with both hands as well.

We never get money from them or from other companies while the medicine is not yet officially approved. After official approval and market access, we will receive a small royalty from the developer. A few of our team members have worked at pharmaceutical companies in the past. That’s why we know the strengths and the weaknesses of that sector. We use that knowledge to improve drug development.

No. We collaborate with any registered and certified doctor and with any hospital that is willing to realize a Fast Track Treatment for patients in need. Having said that, we strongly believe in specialized centers, so we value collaboration with such centers. Whoever we collaborate with, the patient’s best interest always comes first.

Definitely. Patients come first. And in many ways patient organizations in a lot of countries have patient’s best interest at hart. That’s why we feel connected to patient organizations and why we’re more than happy to work with them.

However, not every patient organization has embraced the Fast Track Treatment possibilities that were created by the legislator for patients in need. Some patient organizations have a more traditional approach and emphasize the importance of saying farewell to loved ones at this stage of life. Although we also feel that is important, we focus on the people that want to continue their fight. Other patient organizations keep the interests of their sponsors in mind. We understand that, but we feel that’s not always in the patient’s best interest. And that’s why we choose differently. Politics as well as lobbyists can also greatly influence the policy of a patient organization in some countries. As long as patients better from it, that’s fine. Unfortunately that’s not always the case. At that point we also distance ourselves from such a patient organization. We believe that innovative advancements should be made available as soon as possible. And not just to the happy few, but to as many patients possible that don’t have any time to lose.

 

Because we focus on innovation and advancement, we particularly experience a natural click with patients that took command and founded a new type of patient organization where using the wisdom of the crowd is essential. Great examples are patientslikeme.com and patientsknowbest.org.

We at myTomorrows are social entrepreneurs. Social enterprises focus on solving unmet needs within society. Some social entrepreneurs choose for a charity model, others for a commercial approach. myTomorrows believes innovation and entrepreneurship can change the world. It goes without saying that myTomorrows has chosen the commercial approach of social entrepreneurship in order to create impactful sustainable change. We believe in free entrepreneurship and in organizations that are able to finance themselves. A healthy for-profit attitude creates innovation. Well-meant initiatives like nonprofit organizations risk bureaucracy and inefficiency. That’s why myTomorrows has profit targets, but with a healthy balance between creating meaning and earning money.

We want to help as many patients in need as possible and we don’t make money at a patient’s costs. As long as a medicine that we offer via a Fast Track Treatment isn’t registered yet, myTomorrows doesn’t profit from it. Your patient pays myTomorrows charges that cover the costs to organize a Fast Track Treatment for each patient.

As soon as the medicine is approved and commercially available in a certain region, myTomorrows will start to profit as well. After market approval of the medicine, myTomorrows receives a small royalty from the developer. From that moment onwards we don’t offer the medicine via a Fast Track Treatment anymore in that region, because it’s a registered medicine that is publicly available for patients after market approval.

Progressive doctors from around the globe that have criticized the endless approval processes of medicines, applaud myTomorrows’ initiative. These doctors witness that patients suffer as a result of this. A lot of doctors share the opinion of these progressive doctors, but try to achieve optimal care within the established treatment possibilities. This group may show less activism, but is very interested in our initiative and the opportunities it creates for their patients. And finally, there are doctors that won’t change their way of working until new treatment possibilities are part of the official protocols. However, more and more doctors become aware of the fact that empowered patients want to team up with their doctors and want to be involved in decision making about their treatment.

In order to offer options to patients in need, myTomorrows works with drug developers. Those are mostly small, innovative biotech- and pharma companies. However, if a bigger company wants to create earlier access to one of their promising medicines, we would seize that opportunity with both hands as well.

We never get money from them or from other companies while the medicine is not yet officially approved. After official approval and market access, we will receive a small royalty from the developer. A few of our team members have worked at pharmaceutical companies in the past. That’s why we know the strengths and the weaknesses of that sector. We use that knowledge to improve drug development.

Definitely. Patients always come first. And in many ways patient organizations in a lot of countries have patients’ best interest at hart. That’s why we feel connected to patient organizations and why we’re more than happy to work with them.

However, not every patient organization has embraced the Fast Track Treatment possibilities that were created by the legislator for patients in need. Some patient organizations have a more traditional approach and emphasize the importance of saying farewell to loved ones at this stage of their lives. Although we also feel that this is important, we focus on the people who want to and are able to continue their fight. Other patient organizations keep the interests of their sponsors in mind. We understand that, but we feel that’s not always in the patient’s best interest. And that’s why we choose differently. Politics, as well as lobbyists, can also greatly influence the policy of a patient organization in some countries. As long as patients in need benefit from it, that’s fine. Unfortunately that’s not always the case. At that point we also distance ourselves from such a patient organization. We believe that innovative advancements should be made available as soon as possible. And not just to the happy few, but to as many patients in need as possible.

Because we focus on innovation and advancement, we particularly experience a natural click with patients that took command and founded a new type of patient organization where using the wisdom of the crowd is part of the organization’s DNA. Great examples are patientslikeme.com and patientsknowbest.org.

No. We collaborate with any registered and certified doctor and with any hospital that is willing to realize a Fast Track Treatment for patients. Having said that, we strongly believe in specialized centers, so we value collaboration with such centers. Whoever we collaborate with, the patient’s best interest always comes first.

If you register on our Fighters Community your profile name is public and visible for every visitor. You can choose your profile name when your register. You can also add a photo, indicate that you’re a patient, add your disease and add additional information if you wish to. This information is also public and visible for every visitor.

 

If you register as a patient for a Fast Track Treatment on the platform, a secured medical file will be created for you. This electronic medical file is, for security reasons, entirely separated from your profile on the community. You decide who is allowed to access your medical file.

You can rest assured that your medical details are properly secured. The patient details in our database are encrypted according to established methods that are also being used for international payment transactions between banks. The encryption ensures your details are useless in the unlikely event that other people gain illegal access to the database.

Next to that you can delete your electronic medical file whenever you want. myTomorrows can’t influence this. myTomorrows can only access the anonymized treatment data that don’t include your personal details.

The treatment results you and your doctor add to your electronic medical file are, together with the treatment data from other patients with the same Fast Track Treatment, completely anonymized and uncensored available. We use these data to inform other patients and doctors as much as possible, so they can make an informed decision about whether to start the Fast Track Treatment.

We only select medicines that have proven to be safe during clinical trials. And we provide the necessary information about a Fast Track Treatment that will help you and your doctor to make an informed decision.

Meanwhile you probably know a lot about your disease, but off course your doctor is the expert. Your doctor knows you and your medical history very well. That’s why your doctor is responsible for the advice given to you. Your doctor also remains responsible for your treatment with this medicine

Absolutely not, it’s exactly the other way around. Your needs come first. We often search for promising medicines on behalf of or even with patients like you.

We work within the existing international legislation for early access/compassionate use. Regulatory authorities and professional doctors judge if the medicine prescribed by your doctor – and via myTomorrows earlier accessible – is indeed suitable for you. Only after the regulatory authorities approve the request for treatment with this medicine, myTomorrows can deliver the medicine.

If you register on our Fighters Community your profile name is public and visible for every visitor. You can choose your profile name when your register. You can also add a photo, indicate that you’re a doctor, add the disease you’re interested in and add additional information if you wish to. This information is also public and visible for every visitor.

If your patient registers for a Fast Track Treatment on the platform, a secured medical file will be created for him or her. This electronic medical file is, for security reasons, entirely separated from the profile on the community. Your patient decides who is allowed to access this medical file.

Your patient’s medical details are properly secured. The patient details in our database are encrypted according to established methods that are also being used for international payment transactions between banks. The encryption ensures your patient’s details are useless in the unlikely event that other people gain illegal access to the database.

Next to that your patient can delete the electronic medical file. myTomorrows can’t influence this. myTomorrows can only access the anonymized treatment data of your patient’s file that don’t include personal details.

The treatment results you add to your patient’s electronic medical file are, together with the treatment data from other patients with the same Fast Track Treatment, completely anonymized and uncensored available. We use these data to inform other doctors and their patients as much as possible, so they can make an informed decision about whether to start the Fast Track Treatment.

We only select medicines that have proven to be safe during clinical trials. And we provide the necessary information about a Fast Track Treatment that will help to make an informed decision.

You’re the expert. You know your patient and his medical history. You remain responsible for the treatment of your patient with a Fast Track Treatment medicine.

Absolutely not, it’s exactly the other way around. Your patient’s needs come first. We often search for promising medicines on behalf of or even with patients who are fighting their illness.

We work within the existing international legislation for early access/compassionate use. Regulatory authorities and professional doctors judge if the medicine that’s prescribed by you – and, via myTomorrows, is accessible earlier – is indeed suitable for your patient. Only after the regulatory authorities have approved the request for treatment with this medicine, can myTomorrows deliver the medicine.

Here you can register as a family/friend of a patient to access general information about the Fast Track Treatment.

Here you can sign up for the community where you can connect to patients, family and friends of other patients and doctors. Our Patient Advocates keep an eye on the forum and share relevant information on it as well.

Here you can register if you can’t find a Fast Track Treatment for a disease, but are in need of one for your loved one. Of course we want to help everyone, but as long as we can’t yet, such requests guide us. The more requests we receive regarding a specific disease, the more we will prioritize our search for treatment options.

Do you have unanswered questions that no one within the community could help you with? Feel free to reach out to our team via our contact form or via you@mytomorrows.com. If you have an urgent matter you would like to discuss you can always call on +31 (0)88 52 53 888.

Do you have unanswered questions that no one within the community could help you with? Feel free to reach out to our team via our contact form or via you@mytomorrows.com. If you have an urgent matter you would like to discuss you can always call on +31 (0)88 52 53 888.

Here you can register as a patient to request a Fast Track Treatment. To get earlier access to a promising medicine, your doctor has to sign up as well. You have to be connected to each other on the platform. During each step you’ll receive instructions that help you to effortlessly connect to each other. Registering as a patient to request a Fast Track Treatment happens in a separate part of the website that complies with privacy rules and ISO-safety regulations.

Here you can sign up for the community where you can connect to fellow patients, family and friends of fellow patients and doctors. Our Patient Advocates keep an eye on the forum and share relevant information on it as well.

Here you can register if you can’t find a Fast Track Treatment for a disease, but are in need of one. Of course we want to help everyone, but as long as we can’t yet, questions of patients in need guide us. The more requests we receive regarding a specific disease, the more we will prioritize our search for treatment options.

Here you can register as a doctor to request a Fast Track Treatment. To request earlier access to this promising medicine, your patient has to sign up as well. You have to be connected to each other on the platform. During each step you’ll receive instructions that help you effortlessly connect to each other. Registering for a Fast Track Treatment happens in a separate part of the website that complies with privacy rules and ISO-safety regulations.

Here you can register if you can’t find a Fast Track Treatment for a disease, but are in need of one for your patients. Of course we want to help everyone, but as long as we can’t yet, questions from doctors and their patients in need guide us. The more requests we receive regarding a specific disease, the more we will prioritize our search for treatment options.

If you would like to contact one of our doctors, feel free to reach out to us via our contact form, via you@mytomorrows.com or via +31 (0)88 52 53 888.

No, unfortunately there aren’t. A Fast Track Treatment is always a medicine that at least successfully finished phase I of a clinical trial. At that stage its safety has been tested and there are promising indications about its efficacy. However, there isn’t hard evidence for its efficacy yet. We could also offer a medicine at a more advanced phase of the medicine development. For example during phase 2B of a clinical trial. At that stage there’s more evidence that supports the efficacy of the medicine and that suggests in which group of patients the medicine does or doesn’t shows efficacy.

This means there’s always a chance that the medicine doesn’t better your loved one’s situation (enough). On the other hand there’s a real chance your loved one does benefit from the medicine.

For each disease you can find information about Fast Track Treatments here. We aim to offer multiple Fast Track Treatments for each disease. We are not yet able to offer Fast Track Treatments for every disease. If a disease isn’t mentioned on our website, this means we haven’t found a promising medicine that we were able to discuss with the developer yet. It’s still worthwhile to register at myTomorrows, even if there aren’t Fast Track Treatments available for your patients yet. Questions from patients in need and doctors guide us. If multiple patients and doctors need a treatment for the same disease, we have an extra incentive to research opportunities. And of course we immediately inform you as soon as relevant Fast Track Treatments become available via myTomorrows.

myTomorrows wants to be completely transparent and uncensored towards you as a doctor and your patients about the newest medicines and treatment results. However, communication about medicines is strictly regulated and quickly considered to be surreptitious advertising. And advertising a medicine isn’t at all what myTomorrows aims to do. myTomorrows wants to offer you and your patient the latest options, now that your patient doesn’t have any time to lose. That’s why we are in close contact with regulators to ensure that we can inform you as much as possible about the medicine without name-dropping.

After registration, you as a doctor can access the available information about the Fast Track Treatment medicine such as anonymized real life treatment data from other patients that started this Fast Track Treatment and you can share this information with your patient. Next to that our doctors are more than happy to assist, so you and your patient can make an informed decision based on the latest scientific developments.

No, unfortunately there aren’t. A Fast Track Treatment is always a medicine that at least successfully finished phase I of a clinical trial. At that stage its safety has been tested and there are promising indications about its efficacy. However, there isn’t hard evidence for its efficacy yet. We could also offer a medicine at a more advanced phase of the medicine development. For example during phase 2B of a clinical trial. At that stage there’s more evidence that supports the efficacy of the medicine and that suggests in which group of patients the medicine does or doesn’t shows efficacy.

This means there’s always a chance that the medicine doesn’t better your situation (enough). On the other hand there’s a real chance you do benefit from the medicine.

myTomorrows constantly explores the world in search of promising medicines. We approach companies that have shown promising results with medicines. We judge the medicine, but we also consider whether the company would be a reliable partner for you, your patient and for myTomorrows. We focus on medicines that at least successfully finished phase I of a clinical trial. At that stage its safety has been tested and there are promising efficacy indications. However, there isn’t hard evidence for its efficacy yet. We could also offer a medicine at a later stage of the medicine development, for example during phase 2B of a clinical trial. At that stage there’s more evidence that suggests the medicine’s efficacy. At what moment we offer a medicine via a Fast Track Treatment always depends on the severity of the disease, the rareness of it and the availability of other treatment options for patients in need.

No, unfortunately there aren’t. A Fast Track Treatment is always a medicine that at least successfully finished phase 1 of a clinical trial. At that stage its safety has been tested and there are promising indications about its efficacy. However, there isn’t hard evidence for its efficacy yet. We could also offer a medicine at a more advanced phase of the medicine development. For example during phase 2B of a clinical trial. At that stage there’s more evidence that supports the efficacy of the medicine and that suggests in which group of patients the medicine does or doesn’t shows efficacy.

This means there’s always an actual chance that the medicine doesn’t improve your patient’s situation (enough). On the other hand there’s a real chance your patient does benefit from the medicine.

Yes. A patient cannot start a Fast Track Treatment without the involvement of a registered doctor. We at myTomorrows think it’s up to your patient to decide about his or her own life, so also about the treatment. However, your patient can and should share that responsibility with you as a professional doctor. You are the best partner in making a shared decision about what is best for your patient. So ideally both of you register at myTomorrows. Together you determine if there are still treatment options available.

You as a doctor submit a Fast Track Treatment request to myTomorrows if you want to prescribe the medicine to your patient. From that moment onwards we can take care of things. We check if you are a registered doctor and we take care of the request for approval that will be sent to the regulatory authorities. As soon as the regulatory authorities have reviewed and approved the treatment request and your patient paid for the medicine, your patient’s pharmacy or the hospital pharmacy will receive the medicine via us. You as a doctor remain responsible for your patient’s treatment.

You have to pay for your Fast Track Treatment. We focus on creating earlier access to promising medicines and that is difficult in itself. There are logistic, administrative and legal costs to it. Small innovative drug developers often can’t afford to deliver the medicine for free. We negotiate about a price that reflects a healthy balance between the drug developer’s costs and interests and our aim to make a Fast Track Treatment affordable for as many patients as possible. As long as a medicine isn’t registered yet and available as a Fast Track Treatment via myTomorrows, we don’t profit from it.

In one country health insurers might reimburse a Fast Track Treatment, in another they might not. This differs a lot, so it’s always worthwhile to contact your health insurer and discuss the specific situation.

It would be great if reimbursement wouldn’t be an issue, but reality is what it is. If you’re seriously ill and want to continue to fight your illness, it unfortunately also includes taking ownership of the financial consequences that may come with it.

After approval of a Fast Track Treatment by the regulatory authorities, you receive an invoice from myTomorrows. As soon as that is paid, the medicine can be delivered. If we don’t get approval by the regulatory authorities, you don’t need to pay anything.

We try to make Fast Track Treatments affordable to as many patients as possible. As long as a medicine that we offer via a Fast Track Treatment isn’t registered yet, myTomorrows doesn’t profit from it. Nevertheless, in some cases the costs of a medicine can be very high. And if your health insurer doesn’t cover these costs, it can prove to be difficult to come up with such a sum.

In that case you could consider crowd funding. GiveForward (http://www.giveforward.com) and Indiegogo (http://www.indiegogo.com) are two reliable crowd funding platforms. You can reach out to your social network so they can help you raise the necessary amount for your Fast Track Treatment. Your family and friends, the soccer club, the church community, a business club, etc. We hope this will enable as much patients as possible to start a Fast Track Treatment.

myTomorrows works within the applicable guidelines. Globally there are two types of rules for earlier access to medicines that aren’t registered yet. The first set of rules applies to clinical trials. Drug developers have to successfully conduct such trials on patients before they get market approval for a specific medicine. Due to the strict inclusion criteria, only a small part of the patients, approximately 10%, qualifies to enter such a clinical trial.

There are other guidelines that create opportunities for the other 90% of patients in need. For example: Named Patient and Compassionate Use in The Netherlands, Nominative and Cohort Temporary Authorization for Use in France and Import by a Pharmacist, Compassionate Use and Medical need in Belgium. It’s obvious, local possibilities as well as local regulations differ and the programs are named differently. Because the various national- and international guidelines are complex, we remain in close contact with regulatory authorities around the globe.

Your loved one has to pay for his or her Fast Track Treatment. We focus on creating earlier access to promising medicines and that is difficult in itself. There are logistic, administrative and legal costs to it. Small innovative drug developers often can’t afford to deliver the medicine for free. We negotiate about a price that reflects a healthy balance between the drug developer’s costs and interests and our aim to make a Fast Track Treatment affordable for as many patients as possible. As long as a medicine isn’t registered yet and available as a Fast Track Treatment via myTomorrows, we don’t profit from it.

In one country health insurers might reimburse a Fast Track Treatment, in another they might not. This differs a lot, so it’s always worthwhile for your loved one to contact the health insurer and discuss the specific situation.

It would be great if reimbursement wouldn’t be an issue, but reality is what it is. If your loved one is seriously ill and wants to fight his illness, it unfortunately also includes taking ownership of the financial consequences that may come with it.

After approval of a Fast Track Treatment by the regulatory authorities, your loved one receives an invoice from myTomorrows. As soon as that is paid, the medicine can be delivered. If we don’t get approval by the regulatory authorities, your loved one doesn’t need to pay anything.

Ronald Brus, Sjaak Vink, Erdem Yavuz, Govert Schouten, Jan de Witt, Johan Kleyn, Nathalie ter Wengel and René Beukema founded the company. They are also the initial investors.

We try to make Fast Track Treatments affordable to as many patients as possible. As long as a medicine that we offer via a Fast Track Treatment isn’t registered yet, myTomorrows doesn’t profit from it. Nevertheless, in some cases the costs of a medicine can be very high. And if the health insurer doesn’t cover these costs, it can prove to be difficult to come up with such a sum.

In that case your loved one could consider crowd funding. GiveForward (http://www.giveforward.com) and Indiegogo (http://www.indiegogo.com) are two reliable crowd funding platforms. Your loved one can reach out to his social network so they can help you raise the necessary amount for your Fast Track Treatment. Family and friends, the soccer club, the church community, a business club, etc. We hope this will enable as much patients in need as possible to start a Fast Track Treatment.

myTomorrows works within the applicable guidelines. Globally there are two types of rules for earlier access to medicines that aren’t registered yet. The first set of rules applies to clinical trials. Drug developers have to successfully conduct such trials on patients before they get market approval for a specific medicine. Due to the strict inclusion criteria, only a small part of the patients, approximately 10%, qualifies to enter such a clinical trial.

There are other guidelines that create opportunities for the other 90% of patients in need. For example: Named Patient and Compassionate Use in The Netherlands, Nominative and Cohort Temporary Authorization for Use in France and Import by a Pharmacist, Compassionate Use and Medical need in Belgium. It’s obvious, local possibilities as well as local regulations differ and the programs are named differently. Because the various national- and international guidelines are complex, we remain in close contact with regulatory authorities around the globe.

The patient is responsible for the costs of a Fast Track Treatment. We aim to make a Fast Track Treatment accessible and affordable for as many patients as possible. As long as a medicine isn’t registered yet and available as a Fast Track Treatment via myTomorrows, we don’t profit from it.

Seriously ill people who want to fight their illness unfortunately also have to take ownership of the financial consequences that come with it. In some countries health insurers might reimburse a Fast Track Treatment, in others they might not. Therefore it’s always worthwhile for a patient to contact the health insurer and discuss the specific situation. That’s the responsibility of the patient, not yours.

myTomorrows works within the applicable guidelines. Because the various national- and international guidelines are complex, we remain in close contact with regulatory authorities around the globe.

No. We create freedom of choice. With the support of the doctor and after approval by the regulatory authorities, your loved one can choose earlier access to a promising medicine that is being developed and probably won’t be authorized in time for him. Via the doctor we provide your loved one with the necessary information about the medicine. This will help your loved one and his doctor to make an informed decision together about starting a Fast Track Treatment or not. A Fast Track Treatment is always a medicine that isn’t authorized yet. It could potentially relief your loved one’s suffering, extend his life or even save him. At the same time it has the risk of no efficacy and of unknown side effects. Your loved one should be aware of that.

Ronald Brus, Sjaak Vink, Erdem Yavuz, Govert Schouten, Jan de Witt, Johan Kleyn, Nathalie ter Wengel and René Beukema founded the company. They are also the initial investors.

Ronald Brus, Sjaak Vink, Erdem Yavuz, Govert Schouten, Jan de Witt, Johan Kleyn, Nathalie ter Wengel and René Beukema founded the company. They are also the initial investors.

We at myTomorrows are social entrepreneurs. Social enterprises focus on solving unmet needs within society. Some social entrepreneurs choose for a charity model, others for a commercial approach. myTomorrows believes innovation and entrepreneurship can change the world. It goes without saying that myTomorrows has chosen the commercial approach of social entrepreneurship in order to create impactful sustainable change. We believe in free entrepreneurship and in organizations that are able to finance themselves. A healthy for-profit attitude creates innovation. Well-meant initiatives like nonprofit organizations risk bureaucracy and inefficiency. That is why we at myTomorrows guard a healthy balance between creating meaning and earning money.

We want to help as many patients in need as possible. As long as a medicine that we offer via a Fast Track Treatment isn’t registered yet, myTomorrows doesn’t profit from it. Patients pay myTomorrows charges that cover the costs to organize a Fast Track Treatment for each patient. As soon as the medicine is approved and commercially available in a certain region, myTomorrows will start to profit as well. After market approval of the medicine myTomorrows receives a small royalty.

No. We collaborate with any registered and certified doctor and with any hospital that is willing to realize a Fast Track Treatment for patients. We strongly believe in specialized centers, so we value collaboration with such centers. Whoever we collaborate with, the patient’s best interest always comes first.

Ronald Brus, Sjaak Vink, Erdem Yavuz, Govert Schouten, Jan de Witt, Johan Kleyn, Nathalie ter Wengel and René Beukema founded the company. They are also the initial investors.

Your patient has to pay for his or her Fast Track Treatment. We focus on creating earlier access to promising medicines and that is difficult in itself. There are logistic, administrative and legal costs to it. Small innovative drug developers often can’t afford to deliver the medicine for free. We negotiate a price that reflects a healthy balance between the drug developer’s costs and interests and our aim to make a Fast Track Treatment affordable for as many patients as possible. As long as a medicine isn’t registered yet and available as a Fast Track Treatment via myTomorrows, we don’t profit from it.

If you patient wants to fight his or her illness, unfortunately it also includes taking ownership of the financial consequences that come with it. In some countries health insurers might reimburse a Fast Track Treatment, in others they might not. Therefore it’s always worthwhile for your patient to contact the health insurer and discuss the specific situation.

After approval of a Fast Track Treatment by the regulatory authorities, your patient receives an invoice from myTomorrows. As soon as that is paid for, the medicine can be delivered. If we don’t get approval by the regulatory authorities, your patient doesn’t need to pay anything.

myTomorrows works within the applicable guidelines. We work within the rules for earlier access to promising medicines that are still in development that create opportunities for patients in need. For example: Named Patient and Compassionate Use in The Netherlands, Nominative and Cohort Temporary Authorization for Use in France and Import by a Pharmacist, Compassionate Use and Medical need in Belgium. Obviously, local possibilities as well as local regulations differ and the programs are named differently. Because the various national- and international guidelines are complex, we remain in close contact with regulatory authorities around the globe.

We aim to offer multiple Fast Track Treatments for a disease. If you want to discuss opportunities to offer earlier access to your company’s medicine via a Fast Track Treatment, feel free to contact us via a contact form or via you@mytomorrows.com or via +31 (0)88 5253888.